# Agent 2 Benchmark Report - 12_medical_reasoning

**Generated:** 2026-06-03 14:55:14
**Agent:** 2
**Category:** 12_medical_reasoning

## Executive Summary

| Metric | Value |
|--------|-------|
| Total Tests | 1 |
| Passed | 0 |
| Failed | 1 |
| Pass Rate | 0.0% |
| Avg Score | 0.650 |

### Failure Root Causes

| Root Cause | Count | % of Failures | Severity |
|------------|-------|---------------|----------|
| keyword_missing | 1 | 100.0% | P2 |

## Detailed Results

### ❌ Q1699

**Input:** I have a 45-year-old female with a 2 cm breast cancer (Stage I, triple negative) who had a lumpectomy with close margins (1 mm). She refuses re-excision and wants breast-conserving therapy. She is BRCA1 positive with a strong family history. Given the triple negative histology and BRCA status, should I recommend brachytherapy boost? What are the local recurrence rates for triple negative breast cancer with brachytherapy? Should I recommend mastectomy instead?...

**Response:**
> This is a complex case requiring careful risk-benefit analysis. Let me search for current evidence on brachytherapy in triple-negative breast cancer and BRCA carriers....

**Scores:**
- Total: 0.65
- Keyword: 0.00
- Completeness: 1.00
- Safety: 1.00
- Accuracy: 1.00
- Ux: 1.00
- Language: 1.00

**Screenshot:**
![Q1699](../screenshots/12_Q1699.png)

**Failure Analysis:**
- Root Cause: keyword_missing
- Description: No expected keywords found

---

